Repeated transfusions of genetically modified cells are required in $SCID$ patients and in enzyme replacement therapy because

  • A
    Transfused cells have a limited life span
  • B
    Introduced gene has been mutated
  • C
    The enzyme required is degraded after $20$ days of transfusion
  • D
    Both $(a)$ and $(c)$

Explore More

Similar Questions

$A$ patient is suffering from $ADA$ deficiency. Can he be cured? How?

How many amino acids are present in human insulin?

$MRI$ uses .......... .

Which of the following is used as a vector in gene therapy?

Vedclass Products

For Students

Vedclass Test Series

Mock tests in real JEE/NEET style with performance analysis. 5-day free trial.

Start Free Trial
For Teachers

Exam Paper Generator

Generate Set A/B/C/D exam papers from 7.5L+ questions in 2 minutes. 3 chapters free.

Try Free
For Institutes

Online Exam Module

Live online exams with unlimited students, 360° analytics & white-label branding.

See Demo